Mesa Laboratories (MLAB) to Release Quarterly Earnings on Monday

Mesa Laboratories (NASDAQ:MLABGet Free Report) is expected to be announcing its earnings results before the market opens on Monday, February 3rd. Analysts expect the company to announce earnings of $1.41 per share and revenue of $58,170.00 billion for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Mesa Laboratories (NASDAQ:MLABGet Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $1.81 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.14). Mesa Laboratories had a negative net margin of 107.56% and a positive return on equity of 28.52%. The firm had revenue of $57.83 million for the quarter, compared to the consensus estimate of $58.60 million. On average, analysts expect Mesa Laboratories to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Mesa Laboratories Stock Down 1.4 %

MLAB opened at $140.47 on Monday. The stock has a market cap of $762.75 million, a price-to-earnings ratio of -3.08 and a beta of 0.82. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70. The firm’s fifty day moving average is $128.76 and its 200 day moving average is $124.07. Mesa Laboratories has a fifty-two week low of $83.68 and a fifty-two week high of $149.50.

Mesa Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, February 28th will be given a $0.16 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.46%. Mesa Laboratories’s payout ratio is -1.40%.

Analyst Ratings Changes

Several analysts recently issued reports on the company. StockNews.com cut Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Evercore ISI increased their price objective on shares of Mesa Laboratories from $120.00 to $160.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st.

Get Our Latest Research Report on MLAB

About Mesa Laboratories

(Get Free Report)

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.

Recommended Stories

Earnings History for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.